Twin Tree Management LP Makes New Investment in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Twin Tree Management LP acquired a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 4th quarter, HoldingsChannel reports. The fund acquired 1,991 shares of the company’s stock, valued at approximately $79,000.

Several other hedge funds have also added to or reduced their stakes in the stock. Corient Private Wealth LLC raised its position in Acadia Healthcare by 19.8% in the fourth quarter. Corient Private Wealth LLC now owns 11,426 shares of the company’s stock worth $453,000 after acquiring an additional 1,892 shares during the period. one8zero8 LLC bought a new stake in Acadia Healthcare in the fourth quarter worth about $1,742,000. Natixis Advisors LLC increased its stake in shares of Acadia Healthcare by 0.7% in the fourth quarter. Natixis Advisors LLC now owns 195,291 shares of the company’s stock worth $7,743,000 after purchasing an additional 1,302 shares in the last quarter. Fore Capital LLC purchased a new position in shares of Acadia Healthcare in the fourth quarter worth about $1,190,000. Finally, Swiss National Bank increased its stake in shares of Acadia Healthcare by 0.8% in the fourth quarter. Swiss National Bank now owns 182,568 shares of the company’s stock worth $7,239,000 after purchasing an additional 1,400 shares in the last quarter.

Acadia Healthcare Price Performance

ACHC stock opened at $29.26 on Thursday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare Company, Inc. has a one year low of $27.61 and a one year high of $82.41. The stock has a market cap of $2.72 billion, a PE ratio of 9.59, a P/E/G ratio of 1.46 and a beta of 1.38. The firm has a 50 day simple moving average of $39.20 and a two-hundred day simple moving average of $47.45.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Bank of America reduced their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research note on Friday, February 28th. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. KeyCorp reduced their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a research note on Monday, March 3rd. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their target price for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Finally, TD Cowen reduced their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $56.31.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.